SCHEMBL29469655

SCHEMBL29469655

O=C(NS(=O)(=O)c1ccccc1C(Cl)Cl)c1cc2c(F)cc(N3CC(F)C3)cc2o1

nearest known ligand 0.31

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA9 Q16790 1/20 0.31
CHRM2 P08172 1/20 0.30
CHRM5 P08912 1/20 0.30
CHRM1 P11229 1/20 0.30
CHRM3 P20309 1/20 0.30
MEN1 O00255 1/20 0.30
LMNA P02545 1/20 0.30
KMT2A Q03164 1/20 0.30
KCNH2 Q12809 1/20 0.30
MCHR1 Q99705 1/20 0.30
CFD P00746 1/20 0.30
FLT1 P17948 1/20 0.30
FLT4 P35916 1/20 0.30
KDR P35968 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24333606 1.00 CA12 (0.31) CA12CA1CA9CHRM2CHRM5
SCHEMBL29469665 0.84 ADRA1A (0.35) MEN1KMT2A
SCHEMBL24333611 0.81 CHRM2 (0.31) CHRM2CHRM5CHRM1CHRM3KCNH2
SCHEMBL24333989 0.81 AR (0.34) CHRM1MEN1LMNAKMT2A
SCHEMBL29469708 0.81 ACLY (0.39) CHRM2CHRM1KCNH2MCHR1
SCHEMBL29469635 0.81 F2 (0.32) MEN1LMNAKMT2A
SCHEMBL24334286 0.81 F2 (0.32) MEN1LMNAKMT2A
SCHEMBL24334439 0.81 ACLY (0.39) CHRM2CHRM1KCNH2MCHR1
SCHEMBL24333793 0.81 PKLR (0.34) LMNA
SCHEMBL24333798 0.80 PKLR (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4229048-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute, Inc. (US) 2023-08-23 EP claimed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO claimed
EP-4229048-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute, Inc. (US) 2023-08-23 EP disclosed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed